| Description |
1 online resource (x, 340 pages). |
|
text file |
| Series |
Advances in Alzheimer's Disease ; v. 1
|
|
Advances in Alzheimer's Disease ; v. 1.
|
| Contents |
Title; Preface; Contents; Section 1Overview of Animal Models of Alzheimer's Disease; Estimation of Working Memory in Macaques for Studying Drugs for the Treatment of Cognitive Disorders; The Canine Model of Human Aging and Disease; Unveiling "The Switch" from Aging to Alzheimer's Disease with the Senescence-Accelerated Mouse Model (SAMP8); Alzheimer's Disease Selective Vulnerability and Modelling in Transgenic Mice; The Cholesterol-Fed Rabbit as a Model of AD: The Old, the New and the Pilot; A Rabbit Model of Alzheimer's Disease: Valid at Neuropathological, Cognitive, and Therapeutic Levels. |
|
Transgenic Drosophila Models of Alzheimer's Amyloid-? 42 ToxicitySection 2 Using Animal Models to Understand Mechanisms of Disease; Estrogen, Progesterone and Hippocampal Plasticity in Rodent Models; Apparent Behavioral Benefits of Tau Overexpression in P301L Tau Transgenic Mice; Activation of Cell Cycle Proteins in Transgenic Mice in Response to Neuronal Loss But Not Aß and Tau Pathology; Electron Microscopic 3D Reconstruction Analysis of Amyloid Deposits in 3xTg-AD Mice and Aged Canines; The Cholesterol-Fed Rabbit as a Model System for Cholesterol-Alzheimer's Disease Studies. |
|
Hepatic Ceramide May Mediate Brain Insulin Resistance and Neurodegeneration in Type 2 Diabetes and Non-alcoholic SteatohepatitisAnimal Model of Insulin-Resistant BrainS tate: Intracerebroventricular Streptozotocin Injection Deteriorates Alzheimer-Like Changes in Tg2576 APP-Overexpressing Mice; Hippocampal Alterations in Rats Submitted to Streptozotocin-Induced Dementia Model: Neuroprotection with Aminoguanidine; Section 3 Alzheimer's Disease Therapies Using Animal Models. |
|
Developing Immunotherapies for Alzheimer's Disease Using a Cholesterol-Fed Rabbit Model in the Context of Th Cell DifferentiationAnti-Amyloid-ß Immunotherapy in Alzheimer's Disease: Relevance of Transgenic Mouse Studies to Clinical Trials; Heterogeneity in Red Wine Polyphenolic Contents Differentially Influences Alzheimer's Disease-Type Neuropathology and Cognitive Deterioration; Delivery of NGF to the Brain: Intranasal Versus Ocular Administration in Anti-NGF Transgenic Mice; Cholinomimetic Actions of Memantine on Learning and Hippocampal Plasticity. |
|
Cognitive Performances of Cholinergically Depleted Rats Following Chronic Donepezil AdministrationSubject Index; Author Index. |
| Summary |
Animals have been used to model diseases or test new treatments since around 300 BC and undoubtedly our ability to model disease in animals - including transgenic animals - has provided major breakthroughs in all fields of biomedical research. Due to their complexity and plurality of pathology and symptomatology, the study of neurodegenerative diseases relies heavily on animal models. These models have been developed in many species in the attempt to undercover the complex nature of the disease mechanisms involved. The ultimate goal is to test promising therapies and to manage, prevent or cure. |
| Local Note |
eBooks on EBSCOhost EBSCO eBook Subscription Academic Collection - North America |
| Subject |
Alzheimer's disease -- Animal models -- Handbooks, manuals, etc.
|
|
Alzheimer's disease -- Animal models. |
| Genre/Form |
Handbooks and manuals.
|
|
Electronic books.
|
|
Handbooks and manuals.
|
| Added Author |
Casadesus, Gemma.
|
| Other Form: |
Print version: Casadesus, G. Handbook of Animal Models in Alzheimer's Disease. Amsterdam : IOS Press, ©2011 9781607507321 |
| ISBN |
9781607507338 (electronic book) |
|
1607507331 (electronic book) |
|
1283289687 |
|
9781283289689 |
|
